Diabetes buddy system: weekly calls may help seniors control blood sugar

NCT ID NCT06336122

Recruiting now Disease control Sponsor: The University of Texas Medical Branch, Galveston Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether peer coaching can help older adults (55+) with uncontrolled type 2 diabetes in rural Kentucky better manage their condition. Participants are paired with trained peer coaches who call them weekly or bi-weekly to discuss self-care and goals. The study will compare the two coaching frequencies and measure changes in blood sugar (A1c), diabetes empowerment, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: peer coaching (behavioral intervention)
What this could lead to: If it works, this could show that peer support helps older adults better manage their diabetes, potentially improving blood sugar control and quality of life.
What could go wrong: This is a small, early feasibility study (76 participants) in a specific region, so results may not apply broadly. The intervention is behavioral, so effects may be modest and hard to sustain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Barren River Area Development District
RECRUITING

Bowling Green, Kentucky, 42101, United States
UK HealthCare
RECRUITING

Hazard, Kentucky, 41701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.